title: Adding hydrocortisone as 1st line of inotropic treatment for hypotension in very low birth weight infants.
abstract: In this pilot study the authors demonstrate the feasibility, effectiveness and safety of the combined early treatment with hydrocortisone and dopamine for refractory hypotension in preterm newborns. Very low birth weight infants born at gestational age < 30 wk or birth weight < 1250 g in the first 48 h of life with hypotension after receiving 10-20 mL/kg bolus of normal saline, were randomized to receive concurrently with the initiation of dopamine, intravenous hydrocortisone (11 infants) or an equivalent volume of placebo (11 infants). Despite no significant clinical difference between the groups including gestational age, birth weight, prevalence of chorioamnionitis, prenatal steroid treatment, cord PH, baseline cortisol level, there was a trend towards lower incidence of bronchopulmonary dysplasia (BPD), and higher survival without BPD rate in the hydrocortisone group. In this very sick small group of infants, hydrocortisone was not associated with more adverse effects, but rather showed a trend toward association with better outcome, including survival without BPD.
authors.affiliation: Neonatal Intensive Care Unit, Rambam Medical Center, 6th Haalyia st., Haifa, Israel, ori.inbal@gmail.com.
authors.forename: Ori
authors.initials: O
authors.lastname: Hochwald
authors.forename: Gustavo
authors.initials: G
authors.lastname: Palegra
authors.forename: Horacio
authors.initials: H
authors.lastname: Osiovich
mesh_terms: D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy; D004298:Dopamine / Q000008:administration & dosage; D004311:Double-Blind Method; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007022:Hypotension / Q000188:drug therapy*; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D019102:Infant, Very Low Birth Weight; D008297:Male; D010865:Pilot Projects; D011446:Prospective Studies
chemical_list: D004298:Dopamine; D006854:Hydrocortisone
references.citation: Annu Rev Physiol. 1997;59:365-93
references.pmid: 9074769
references.citation: J Perinatol. 2005 Feb;25(2):119-24
references.pmid: 15329742
references.citation: Arch Dis Child Fetal Neonatal Ed. 2004 Mar;89(2):F119-26
references.pmid: 14977894
references.citation: Semin Neonatol. 2004 Feb;9(1):13-21
references.pmid: 15013472
references.citation: Pediatrics. 2006 Feb;117(2):367-75
references.pmid: 16452355
references.citation: Semin Neonatol. 2003 Dec;8(6):413-23
references.pmid: 15001113
references.citation: Arch Dis Child Fetal Neonatal Ed. 2003 Nov;88(6):F450-4
references.pmid: 14602688
references.citation: Pediatrics. 2004 Dec;114(6):1649-57
references.pmid: 15574629
references.citation: Pediatrics. 2001 May;107(5):1070-4
references.pmid: 11331688
references.citation: Arch Dis Child Fetal Neonatal Ed. 1999 Nov;81(3):F171-4
references.pmid: 10525017